FIELD: medicine.
SUBSTANCE: invention relates to a method for the long-term treatment of type 2 diabetes mellitus in a subject in need thereof. The method of treatment includes administering to a subject a compound being a carbapenem in an effective amount. Here, long-term treatment of type 2 diabetes is the treatment of a symptom of type 2 diabetes for at least one week after administration of the compound.
EFFECT: invention provides long-acting treatment for type 2 diabetes with the treatment effect lasting for at least one week even after the medicinal product discontinuation, which improves the quality of life of patients and their adherence to treatment.
6 cl, 6 dwg, 14 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BETA-LACTAM COMPOUNDS OR SALTS THEREOF FOR USE IN LONG-TERM PREVENTION OR TREATMENT OF IMPAIRED GLUCOSE METABOLISM | 2020 |
|
RU2830748C2 |
| COMPOSITION USED TO COMBAT METABOLIC DISEASES AND USE OF COMPOSITION | 2020 |
|
RU2827553C1 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
| CANCER MODELS AND CORRESPONDING METHODS | 2014 |
|
RU2707531C2 |
| HIGH-PENETRATION PRODRUG COMPOSITIONS BASED ON PEPTIDES AND PEPTIDE-RELATED COMPOUNDS | 2010 |
|
RU2767051C2 |
| COMPOSITIONS OF INTENSIVE PENETRATION AND THEIR APPLICATION | 2009 |
|
RU2630577C2 |
| COMPOSITIONS, APPLICATIONS AND METHODS OF TREATING METABOLIC DISORDERS AND DISEASES | 2012 |
|
RU2697762C2 |
| METHOD OF TREATING HYPERGLYCAEMIA | 2017 |
|
RU2739255C2 |
| PHARMACEUTICAL AGENTS, COMPOSITIONS, AND METHODS RELATED THERETO | 2018 |
|
RU2765286C2 |
| COMPOUNDS FOR METABOLIC DISORDER TREATMENT | 2004 |
|
RU2358722C2 |
